会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明申请
    • Coenzyme Q compositions persisting in blood
    • 辅酶Q组合物持续存在血液
    • US20060073131A1
    • 2006-04-06
    • US11085181
    • 2005-03-22
    • Kenji FujiiTaizo KawabeHiroshi Kubo
    • Kenji FujiiTaizo KawabeHiroshi Kubo
    • A61K38/43A61K31/12
    • A61K31/122Y10S514/824Y10S514/878Y10S514/879
    • The object of the present invention is to provide a composition maintaining a blood coenzyme Q concentration at a high level in blood for a prolonged period of time, in order to surely attain an effect of coenzyme Q, which can be expected to manifest a superior effect in maintaining health in humans and animals. By using a composition which comprises a coenzyme Q being a mixture of a reduced coenzyme Q and an oxidized coenzyme Q with the proportion of the reduced coenzyme Q to the whole coenzyme Q of more than 95% by weight, the present invention can attain a high maximum blood concentration of a coenzyme Q as well as long maintenance of high concentration of coenzyme Q in blood for a prolonged period of time, and the area under the blood concentration curve (AUC) can be expanded.
    • 本发明的目的是提供一种维持血液辅酶Q浓度在血液中长时间保持的组合物,以确保达到辅酶Q的效果,其可以预期表现出优异的效果 维持人类和动物的健康。 通过使用包含还原型辅酶Q和还原型辅酶Q的还原型辅酶Q与整个辅酶Q的比例大于95重量%的辅酶Q的混合物的组合物,本发明可以达到高 辅酶Q的最大血液浓度以及血液中长时间维持高浓度辅酶Q长时间,血液浓度曲线下面积(AUC)可以扩大。
    • 6. 发明授权
    • Coenzyme Q compositions persisting in blood
    • 辅酶Q组合物持续存在血液
    • US07708990B2
    • 2010-05-04
    • US11085181
    • 2005-03-22
    • Kenji FujiiTaizo KawabeHiroshi Kubo
    • Kenji FujiiTaizo KawabeHiroshi Kubo
    • A61K38/43A01N31/14
    • A61K31/122Y10S514/824Y10S514/878Y10S514/879
    • The object of the present invention is to provide a composition maintaining a blood coenzyme Q concentration at a high level in blood for a prolonged period of time, in order to surely attain an effect of coenzyme Q, which can be expected to manifest a superior effect in maintaining health in humans and animals.By using a composition which comprises a coenzyme Q being a mixture of a reduced coenzyme Q and an oxidized coenzyme Q with the proportion of the reduced coenzyme Q to the whole coenzyme Q of more than 95% by weight, the present invention can attain a high maximum blood concentration of a coenzyme Q as well as long maintenance of high concentration of coenzyme Q in blood for a prolonged period of time, and the area under the blood concentration curve (AUC) can be expanded.
    • 本发明的目的是提供一种维持血液辅酶Q浓度在血液中长时间保持的组合物,以确保达到辅酶Q的效果,其可以预期表现出优异的效果 维持人类和动物的健康。 通过使用包含还原型辅酶Q和还原型辅酶Q的还原型辅酶Q与整个辅酶Q的比例大于95重量%的辅酶Q的混合物的组合物,本发明可以达到高 辅酶Q的最大血液浓度以及血液中长时间维持高浓度辅酶Q长时间,血液浓度曲线下面积(AUC)可以扩大。
    • 8. 发明授权
    • Fatigue reducing agent
    • 减疲劳剂
    • US08946303B2
    • 2015-02-03
    • US10541020
    • 2004-01-19
    • Kenji FujiiTaizo KawabeKazunori HosoeTakayoshi Hidaka
    • Kenji FujiiTaizo KawabeKazunori HosoeTakayoshi Hidaka
    • A61K31/122A61K38/43A61K38/44A61K31/09
    • A61K31/09A61K31/122
    • To maintain physical fitness and health of middle-aged and older persons living in the threshold of the aging society, the present invention provides a fatigue reducing agent which is highly effective for preventing and reducing fatigue, wherein the agent is made of a composition of substances that are very safe so that long-term administration is possible. A composition containing reduced coenzyme Q was found to be effective for preventing and reducing fatigue, including muscle fatigue. Since the fatigue reducing effect of the composition of the present invention is seen not only in young rats but also more pronounced in aged rats, the present invention can provide the fatigue reducing agent which is very useful, especially, for middle-aged and older persons as well as for young people.
    • 为了保持生活在老龄化社会门槛的中老年人的身体健康和健康,本发明提供了一种对预防和减轻疲劳高度有效的疲劳减轻剂,其中药剂由物质组成 这是非常安全的,以便长期管理是可能的。 发现含有还原型辅酶Q的组合物可有效预防和减少疲劳,包括肌肉疲劳。 由于本发明的组合物的疲劳降低效果不仅在年轻大鼠中被观察到,而且在老年大鼠中也更加显着,本发明可以提供非常有用的疲劳减轻剂,特别是对于中老年人 以及年轻人。